A set a antiepileptic drugs (AED) that are active against the MES test, inc
luding structures that are already in clinical use as well as the new compo
unds recently designed in our lab, is analyzed in this article in relation
to the requirements associated with the manifested activity, The strategy i
nvolves the identification of the pharmacophoric pattern, by means of a sim
ilarity analysis where the structural and electronic characteristics are co
mpared, followed by a QSAR study. The latter shows the importance of the el
ectronic descriptors, and points to the carbonyl group as the most relevant
portion for the definition of the activity. Quantum chemical derived descr
iptors give the best answer for both the similarity analysis and the statis
tical fitting. (C) 2000 Elsevier Science B.V. All rights reserved.